Skip to content

Study of Antibiotics in Cerebrospinal Fluid Following Intravenous Injection

Antibiotics in Cerebrospinal Fluid Following Intravenous Injection

Status
Withdrawn
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00925093
Enrollment
0
Registered
2009-06-19
Start date
2011-09-30
Completion date
2013-12-31
Last updated
2015-01-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neurosurgery

Keywords

vancomycin, teicoplanin, linezolid, intravenous, cerebrospinal fluid, CSF, pharmacokinetics, penetration, blood-brain barrier, Pharmacokinetics of three antibiotics in relation to cerebrospinal fluid

Brief summary

Three different antibiotics are used to prevent infection in case of neurosurgery - this study examines to which extent the antibiotics penetrate from the blood to the cerebrospinal fluid (surrounding the brain).

Interventions

DRUGVancomycin

Vancomycin is administered intravenously and subsequently measured in cerebrospinal fluid sample

DRUGTeicoplanin

Teicoplanin is administered intravenously and subsequently measured in cerebrospinal fluid sample

DRUGLinezolid

Linezolid is administered intravenously and subsequently measured in cerebrospinal fluid sample

Sponsors

Aarhus University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Over 18 years old * Already having an external CSF drain * Scheduled for neurosurgery requiring antibiotic prophylaxis (most commonly placement of an internal drain (shunt)

Exclusion criteria

* Infection or colonization requiring other than standard prophylactic antibiotics

Design outcomes

Primary

MeasureTime frameDescription
Concentration of antibiotics in cerebrospinal fluid1, 2, 4, 6, 12 hoursConcentration in CSF past i.v. injection

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026